Postmarket Transformation Plan Update With FDA’s Don St. Pierre
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center set out on an ambitious path last year to revamp the way it oversees product safety in what it is calling its 1"postmarket transformation" initiative